These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6137871)
21. The schizophrenic mind. Begley S Newsweek; 2002 Mar; 139(10):44-51. PubMed ID: 11894588 [No Abstract] [Full Text] [Related]
22. Recent concepts in clinical psychiatry: drug treatment in schizophrenia. Hussain SH J Pak Med Assoc; 1991 Sep; 41(9):229-34. PubMed ID: 1683911 [No Abstract] [Full Text] [Related]
23. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. Carlsson A; Hansson LO; Waters N; Carlsson ML Life Sci; 1997; 61(2):75-94. PubMed ID: 9217267 [TBL] [Abstract][Full Text] [Related]
24. Response to 'signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia'. Christie AC Aust N Z J Psychiatry; 2001 Jun; 35(3):386-8. PubMed ID: 11437816 [No Abstract] [Full Text] [Related]
25. Treatment of schizophrenia and spectrum disorders: pharmacotherapy, psychosocial treatments, and neurotransmitter interactions. Meltzer HY Biol Psychiatry; 1999 Nov; 46(10):1321-7. PubMed ID: 10578448 [No Abstract] [Full Text] [Related]
27. Phenomenological modelling of some mechanisms in schizophrenia. Schwegler H Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S43-9. PubMed ID: 16508895 [TBL] [Abstract][Full Text] [Related]
28. Treatment of cognitive dysfunction in schizophrenia. Peuskens J; Demily C; Thibaut F Clin Ther; 2005; 27 Suppl A():S25-37. PubMed ID: 16198199 [TBL] [Abstract][Full Text] [Related]
29. [Transmitter dysfunction in patients with schizophrenia. Significance for cognitive functioning and treatment]. Glenthøj BY; Mackeprang T; Bille AE; Hemmingsen RP Ugeskr Laeger; 1999 Mar; 161(10):1391-8. PubMed ID: 10085745 [TBL] [Abstract][Full Text] [Related]
30. Recent advances in the pharmacotherapy of schizophrenia. Lapierre YD Psychiatr J Univ Ott; 1983 Jun; 8(2):81-5. PubMed ID: 6137017 [No Abstract] [Full Text] [Related]
31. A motivational theory of psychopathology. Fowles DC Nebr Symp Motiv; 1994; 41():181-238. PubMed ID: 7739747 [No Abstract] [Full Text] [Related]
32. Identify the specific role of regional changes for the complex symptoms of schizophrenia. Tretter F; Müller WE; Carlsson A Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S1-2. PubMed ID: 16508887 [No Abstract] [Full Text] [Related]
33. Cognitive neuroscience and schizophrenia: translational research in need of a translator. Cohen JD; Insel TR Biol Psychiatry; 2008 Jul; 64(1):2-3. PubMed ID: 18549873 [No Abstract] [Full Text] [Related]
34. Being rational. Stefanidis E Schizophr Bull; 2006 Jul; 32(3):422-3. PubMed ID: 16192408 [No Abstract] [Full Text] [Related]
35. Clozapine: the Yin and Yang of seizures and psychosis. Stevens JR Biol Psychiatry; 1995 Apr; 37(7):425-6. PubMed ID: 7786954 [No Abstract] [Full Text] [Related]
36. [A biochemical theory of schizophrenia]. Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120 [TBL] [Abstract][Full Text] [Related]
37. Capitalizing on extrasynaptic glutamate neurotransmission to treat antipsychotic-resistant symptoms in schizophrenia. Krystal JH Biol Psychiatry; 2008 Sep; 64(5):358-60. PubMed ID: 18694665 [No Abstract] [Full Text] [Related]
38. Pharmacotherapy of schizophrenia: a review. Sigmundson HK Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053 [TBL] [Abstract][Full Text] [Related]
39. A few important points about dopamine's role in neural network dynamics. Durstewitz D Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S72-5. PubMed ID: 16508901 [TBL] [Abstract][Full Text] [Related]